Comments
Dr Reddy’s Laboratories Ltd has announced the first-to-market launch of naproxen and esomeprazole magnesium delayed-release tablets. They are the therapeutic equivalent generic version of Vimovo, approved by the US Food and Drug Administration (USFDA).
“This launch is a testament to our core strengths in the areas of research and development and intellectual property,” Marc Kikuchi, Chief Executive Officer, North America Generics, Dr Reddy’s, said in a release. “We are excited to be a part of forming the first generic market for Vimovo tablets and to provide an affordable treatment alternative for patients.”
The Vimovo brand had US sales of approximately $414 million for the 12 months ended December 2019, according to IQVIA Health.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.